Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Impact Regulatory News (PIM)

  • There is currently no data for PIM

R&D Platform and Pipeline Presentation

15 Aug 2017 07:00

RNS Number : 9748N
Plant Impact PLC
15 August 2017
 

 

For immediate release

 

15 August 2017

 

RNS Reach

Plant Impact Plc

("Plant Impact" or the "Group")

 

Research & Development Platform and Pipeline Presentation

 

Plant Impact plc (AIM: PIM), a leader in research and development in crop enhancement products that growers can rely on to improve the yield and quality of crops, is pleased to publish the first presentation on its research and development ("R&D") platform and pipeline. The full presentation can be found at

www.plantimpact.com/investors

 

The Group's R&D platform is highly differentiated within the emerging crop enhancement sector and is focused on bringing products to market over the next 5 years, with the first pipeline product expected to launched by 2020. The platform begins with an understanding of key yield-limiting physiological and biochemical plant responses. It then prioritises soybean and wheat as model dicot and monocot crops to enable future diversification into other crops such as cotton and corn, and utilises novel synthetic and small molecule chemistry. This methodology generates targeted foliar and seed treatment products.

 

The R&D presentation sets out the following:

 

· Industry - the case for crop enhancement and the current landscape

· Business - structure and history (with an R&D focus)

· Research and technology - platform design, screening process and the case for chemistry

· Pipeline and products - pipeline stages, case studies and focus areas

· Markets - activity overviews and case studies for key markets

· Financial model - corporate value streams, indicative peak annual sales opportunity for pipeline products and an explanation of revenue streams included/excluded from external guidance

· Market estimates (appendix) - methodology used to estimate the indicative market sizes for R&D focus areas

 

Plant Impact believes that crop enhancement will grow to be a significant sector within the chemical and biological farming inputs market, playing a key role in sustainably improving food security worldwide by using new technologies to help growers improve global crop yields.

 

John Brubaker, CEO, said: "Growth and innovation in the crop enhancement sector is accelerating more rapidly than ever before and at Plant Impact we are proud to be at the forefront of R&D advances in synthetic and small molecule chemistry. This is our first R&D presentation; it establishes a new level of clarity on our pipeline and it will be updated regularly. I would like to thank our shareholders for their continued support."

 

 

For further information, contact:

 

Plant Impact

John Brubaker, Chief Executive Officer Tel: +44(0) 1582 465 540

Richard Amos, Chief Financial Officer

Ailish Tracy, Global Communications Manager

www.plantimpact.com

 

Peel Hunt - Nominated Advisor and Broker

Adrian Trimmings Tel: +44 (0) 207 418 8900

George Sellar

 

Buchanan

Mark Court Tel: +44(0) 20 7466 5000

Jamie Hooper

Sophie Cowles

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALLFETTAISLID
Date   Source Headline
14th Dec 20172:48 pmRNSForm 8.3 - Plant Impact PLC
14th Dec 20172:17 pmRNSForm 8.3 - Plant Impact plc
14th Dec 201712:00 pmRNSForm 8.5 (EPT/RI) Plant Impact Plc
13th Dec 20177:00 amRNSUpdate, Strategic Options and Formal Sale Process
24th Oct 20177:00 amRNSPosting of Annual Report and Notice of AGM
17th Oct 20175:27 pmRNSNotification of Major Holdings
9th Oct 20177:00 amRNSPreliminary Results
27th Sep 20177:00 amRNSNotice of Preliminary Results
20th Sep 20172:40 pmRNSNotification of Major Holdings
15th Aug 20177:00 amRNSR&D Platform and Pipeline Presentation
2nd Aug 20178:46 amRNSTR-1: Notification of Major Holdings
1st Aug 20174:46 pmRNSTR-1: Notification of major holdings
1st Aug 201710:42 amRNSTOTAL VOTING RIGHTS
31st Jul 20173:48 pmRNSNOTIFICATION OF MAJOR HOLDINGS
28th Jul 20173:59 pmRNSDirector/PDMR Shareholding
28th Jul 20173:48 pmRNSNotification of Major Interest in Shares
28th Jul 20173:43 pmRNSNotification of Major Interest in Shares
26th Jul 20173:25 pmRNSBLOCK LISTING SIX MONTHLY RETURN
26th Jul 20177:00 amRNSProposed Placing
17th Jul 20177:00 amRNSFull Year Trading Update & Potential Capital Raise
19th Jun 20177:00 amRNSThird Quarter Trading Update
3rd May 20177:00 amRNSNew collaboration with Ghent University
6th Mar 20177:00 amRNSHalf year results
22nd Feb 20175:00 pmRNSUSA launch of Fortalis®
8th Feb 20177:00 amRNSNew Quality Standard
12th Jan 20177:30 amRNSBLOCK LISTING SIX MONTHLY RETURN
12th Jan 20177:00 amRNSCORRECTION OF BLOCK LISTING SIX MONTHLY RETURN
9th Dec 20162:17 pmRNSRESULTS OF ANNUAL GENERAL MEETING
9th Dec 20167:00 amRNSAGM Trading Update
2nd Dec 20167:00 amRNSTotal Voting Rights
10th Nov 20167:00 amRNSPosting of Annual Report and Notice of AGM
31st Oct 20167:00 amRNSPreliminary Results
19th Aug 20167:00 amRNSAdoption of FRS 101
3rd Aug 20165:03 pmRNSTotal Voting Rights
6th Jul 20167:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
1st Jul 20167:00 amRNSNew Product Intro & Launch of Southern Cone Ops
14th Jun 20167:00 amRNSTrading update
19th May 20167:00 amRNSOption Grant to Recently Appointed CFO
10th May 20167:00 amRNSAppointment of Chief Financial Officer
20th Apr 20167:00 amRNSScientific Advisory Network
6th Apr 20163:55 pmRNSDirector's Dealing
4th Apr 20168:26 amRNSTotal Voting Rights
21st Mar 20167:00 amRNSHalf yearly results
16th Mar 20167:00 amRNSCollaboration on mitigating heat stress in wheat
7th Mar 20167:00 amRNSNotification of Half Year Results
2nd Mar 20163:48 pmRNSTotal Voting Rights
24th Feb 20167:00 amRNSNotification of Major Interest in Shares
19th Feb 20165:19 pmRNSBlock Listing Six Monthly Return
18th Feb 20167:00 amRNSNorth America Operations: Key Senior Appointment
15th Feb 20162:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.